Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2622504 | 0.84 | TK1 (0.47) | TK1 | |
| Phosphoric Acid SCHEMBL7220598 | 0.84 | TK1 (0.59) | TK1 | |
| SCHEMBL2231702 | 0.81 | TK1 (0.64) | TK1 | |
| SCHEMBL13669402 | 0.81 | TK1 (0.64) | TK1 | |
| SCHEMBL5532799 | 0.81 | TK1 (0.64) | TK1 | |
| SCHEMBL13258664 | 0.81 | TYMS (0.55) | — | |
| SCHEMBL13644730 | 0.81 | TK1 (0.53) | TK1 | |
| SCHEMBL12133411 | 0.81 | TK1 (0.45) | TK1 | |
| SCHEMBL20074268 | 0.80 | POLB (0.55) | — | |
| SCHEMBL304477 | 0.80 | POLB (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3848380-A1 | LABELLED NUCLEOTIDES | Illumina Cambridge Limited (GB) | 2021-07-14 | — | — | EP | disclosed |
| US-11028116-B2 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-06-08 | — | — | US | disclosed |
| US-11028115-B2 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-06-08 | — | — | US | disclosed |
| US-11008359-B2 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-05-18 | — | — | US | disclosed |
| US-10995111-B2 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-05-04 | — | — | US | disclosed |
| US-20210047357-A1 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2021-02-18 | — | — | US | disclosed |
| EP-3438116-B1 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LTD (GB) | 2021-02-17 | — | — | EP | disclosed |
| US-20210009622-A1 | LABELLED NUCLEOTIDES | SOLEXA LIMITED (GB) | 2021-01-14 | — | — | US | disclosed |
| US-20210009623-A1 | LABELLED NUCLEOTIDES | SOLEXA LIMITED (GB) | 2021-01-14 | — | — | US | disclosed |
| US-20200325167-A1 | LABELLED NUCLEOTIDES | SOLEXA LIMITED (GB) | 2020-10-15 | — | — | US | disclosed |
| US-20140141414-A1 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2014-05-22 | — | — | US | disclosed |
| US-20120156671-A1 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LIMITED (GB) | 2012-06-21 | — | — | US | disclosed |
| US-8084590-B2 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2011-12-27 | — | — | US | disclosed |
| US-20100311178-A1 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED | 2010-12-09 | — | — | US | disclosed |
| US-7795424-B2 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2010-09-14 | — | — | US | disclosed |
| EP-2119722-A1 | Labelled nucleotides | Illumina Cambridge Limited (GB) | 2009-11-18 | — | — | EP | disclosed |
| EP-1560838-B1 | LABELLED NUCLEOTIDES | ILLUMINA CAMBRIDGE LTD (GB) | 2009-05-13 | — | — | EP | disclosed |
| US-20090062145-A1 | Labelled nucleotides | ILLUMINA CAMBRIDGE LIMITED (GB) | 2009-03-05 | — | — | US | disclosed |
| US-7414116-B2 | certain linkers connecting nucleotide bases to detachable labels (fluorophores) are cleaved using water soluble phosphines transition metal catalysts; sequencing; used in nick translation, random primer labeling, end-labeling (terminal deoxynucleotidyltransferase), reverse transcription, amplification | ILLUMINA CAMBRIDGE LIMITED (GB) | 2008-08-19 | — | — | US | disclosed |
| US-20060160081-A1 | certain linkers connecting nucleotide bases to detachable labels (fluorophores) are cleaved using water soluble phosphines transition metal catalysts; sequencing; used in nick translation, random primer labeling, end-labeling (terminal deoxynucleotidyltransferase), reverse transcription, amplification | ILLUMINA CAMBRIDGE LIMITED (GB) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200325167-A1 | LABELLED NUCLEOTIDES | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-20060160081-A1 | certain linkers connecting nucleotide bases to detachable labels (fluorophores) are cleaved using water soluble phosphines transition metal catalysts; sequencing; used in nick translation, random primer labeling, end-labeling (terminal deoxynucleotidyltransferase), reverse transcription, amplification | RNGTT, DNTT, POLQ | TK1 20/4885 |
| US-20210009623-A1 | LABELLED NUCLEOTIDES | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-20210009622-A1 | LABELLED NUCLEOTIDES | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-11008359-B2 | Labelled nucleotides | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-20100311178-A1 | Labelled nucleotides | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-20210047357-A1 | LABELLED NUCLEOTIDES | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-10995111-B2 | Labelled nucleotides | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-11028116-B2 | Labelled nucleotides | NUDT1, DUT, NT5C2 | TK1 22/4885 |
| US-11028115-B2 | Labelled nucleotides | NUDT1, DUT, NT5C2 | TK1 22/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.